Download full-text PDF |
Source |
---|
Front Aging Neurosci
October 2022
Department of Medical Innovation, Osaka University Hospital, Osaka, Japan.
Background: Several medications have been applied to Alzheimer's dementia patients (AD) but their efficacies have been insufficient. The efficacy and safety of 4 weeks of repetitive transcranial magnetic stimulation (rTMS) in Japanese AD were evaluated in this exploratory clinical trial.
Methods: Forty-two patients, aged 60-93 years (average, 76.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!